COVID-19 Safety Precautions: Find the Latest Visitor and Mask Policies. Learn More
Inflammatory Breast Cancer Clinical Trials
Inflammatory breast cancer clinical trials provide patients with access to the very latest in treatment options, and also help researchers identify new and better ways to address this relatively rare condition. As a high-volume specialty cancer center, Moffitt Cancer Center is able to offer concentrated programs dedicated to treating even the rarest cancers. As a result, our patients continually benefit from our extensive knowledge and experience.
In addition to providing patients with opportunities to be among the first to take advantage of new treatments, inflammatory breast cancer clinical trials allow researchers to continually improve the standard of care for all patients. For example, consider that important research studies performed during the last decade have provided physicians with the information to modify the prevailing treatments for other types of breast cancer, such as surgery, chemotherapy, radiation treatment and hormone therapy, so that those treatments are now suitable and effective for inflammatory breast cancer patients.
Prior to proposing inflammatory breast cancer clinical trials, a physician at Moffitt will carefully screen each potential patient. The purpose of the qualification process is two-fold:
- First, the physician must confirm that the proposed treatment is suitable for the patient.
- Second, clinical trial participants must necessarily meet certain qualifications in order to ensure that researchers are able to obtain the most meaningful and accurate results from the study.
With our robust portfolio of clinical trials, Moffitt continues to pave the way for cancer research. As a result, our patients have access to unique opportunities to both improve their own outcomes and contribute to our growing base of scientific knowledge for the benefit of all patients. In recognition of our efforts, we have been designated as the only National Cancer Institute Comprehensive Cancer Center based in Florida.
To discuss inflammatory breast cancer clinical trials with our clinical trial navigators, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online. We do not require referrals.